Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 249

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 249
---
| Total share capital                       |     |         3,522.91 |     |       3,527.08 |     |       3,531.25 |

____________ Notes:- (i)Corresponds to 3,342,188 Company Shares to be issued to Sponsor. (ii)Corresponds to 970,312 Company Shares to be issued to the Initial Sponsor. (iii)Prior to Closing, the Parent expects to redeem a portion of the Parent shares held by Theo, and Theo expects to subsequently distribute a total of 1,500,000 Company Shares to between 300 and 424shareholders of Bioceres S.A. and Bioceres Group so that the Company will comply with Nasdaq listing requirements.

112

(iv)Company Shares issued to Theo pursuant to the Backstop Agreement assuming that it satisfies its obligations thereunder pursuant to the subscription of 1,000,000 Company Shares at an issue price of $10.00 per Company Share. See “ Certain Agreements Related to the Business Combination — Backstop Agreement.” The preceding table does not consider Company Shares that may be issued to Earlybird pursuant to the EarlyBird Engagement Letter, which provides that, if the Business Combination closes, EarlyBird is entitled to the EarlyBird Fees, comprising of $2,000,000, of which up to $500,000 may be payable in Company Shares on the six -monthanniversary of the Closing. If the Closing does not occur, EarlyBird will not be entitled to the EarlyBird Fees. For more information, see “ Certain Agreements Relating to the Business Combination — EarlyBird Engagement Letter.” Share Premium The determination of share premium according to the contributions to the combined entity is set out below:

|                                                            |     |     Scenario 1 – 
      Assuming no 
      redemptions |   |     |   Scenario 2 – 
   Assuming 50% 
 of redemptions |   |     |   Scenario 3 – 
  Assuming 100% 
 of redemptions |      |
|                                                            |     | -in U.S. dollars |   |     |                |   |     |                |      |
| Current OmnigenicsAI                                       |     |        2,828,281 |   |     |      2,828,281 |   |     |      2,828,281 |      |
| Share premium – OmnigenicsAI shareholders(i)               |     |        2,828,281 |